Johanna Edlmayr

Title: Johanna Edlmayr: Innovator in Rhinovirus Diagnosis

Introduction

Johanna Edlmayr is a notable inventor based in Munich, Germany. She has made significant contributions to the field of pharmaceutical sciences, particularly in the diagnosis of viral infections. Her innovative work has led to the development of a unique method for diagnosing rhinovirus infections.

Latest Patents

Johanna Edlmayr holds a patent for a "Method for diagnosing a rhinovirus infection." This invention relates to a pharmaceutical composition that includes at least one peptide consisting of a minimum of 8 and a maximum of 50 amino acid residues. The composition specifically comprises amino acid residues 1 to 8 of a rhinovirus capsid protein selected from the group consisting of VP1, VP2, VP3, and VP4. This patent highlights her expertise in virology and pharmaceutical development.

Career Highlights

Throughout her career, Johanna has worked with various companies, including Viravaxx GmbH and Viravaxx AG. Her experience in these organizations has allowed her to apply her research in practical settings, contributing to advancements in medical diagnostics.

Collaborations

Johanna has collaborated with esteemed colleagues such as Rudolf Valenta and Katarzyna Niespodziana. These partnerships have enriched her research and expanded the impact of her innovations in the field.

Conclusion

Johanna Edlmayr's contributions to the diagnosis of rhinovirus infections exemplify her dedication to advancing medical science. Her innovative methods and collaborations with other experts continue to influence the field positively.